Document is current
Any future updates will be listed below
-
Authors
Mackin, Samantha R. https://orcid.org/0000-0003-4518-1274
Desai, Pritesh https://orcid.org/0000-0002-4697-9475
Whitener, Bradley M.
Karl, Courtney E.
Liu, Meizi https://orcid.org/0000-0002-7633-3384
Baric, Ralph S.
Edwards, Darin K. https://orcid.org/0000-0002-2065-2941
Chicz, Taras M. https://orcid.org/0000-0002-5204-2507
McNamara, Ryan P.
Alter, Galit
Diamond, Michael S. https://orcid.org/0000-0002-8791-3165
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI157155)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93019C00051)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (T32 AI007172)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI110700)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI157155)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01 AI1650721)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (P01 AI1650721)
- License Information
-
More Information
Article History
Received: 9 February 2023
Accepted: 10 March 2023
First Online: 3 April 2023
Competing interests
: M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences, Moderna, Ocugen and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions, Generate Biomedicines and Moderna. R.S.B. is a member of the Scientific Advisory Board of VaxArt and Adagio, has consulted for Takeda and received unrelated funding from J&J and Pfizer. G.A. is a founder/equity holder in Seroymx Systems and Leyden Labs and has served as a scientific advisor for Sanofi Vaccines. G.A. has collaborative agreements with GlaxoSmithKline, Merck, Abbvie, Sanofi, Medicago, BioNtech, Moderna, BMS, Novavax, SK Biosciences, Gilead and Sanaria. D.K.E. and G.A. are employees and shareholders in Moderna, Inc. All other authors declare no conflicts of interest.
Free to read: This content has been made available to all.
